AcouSort AB ACOU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 10.20
- Day Range
- SEK 9.32–10.65
- 52-Week Range
- SEK 9.32–30.76
- Bid/Ask
- SEK 10.30 / SEK 10.50
- Market Cap
- SEK 155.75 Mil
- Volume/Avg
- 36,833 / 29,524
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 23.11
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company products include AcouTrap, AcouWash, and AcouPlasma.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 17
- Website
- https://www.acousort.com
Valuation
|
Metric
|
ACOU
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.94 |
Price/Sales | 23.11 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ACOU
|
|---|---|
Quick Ratio | 2.76 |
Current Ratio | 2.96 |
Interest Coverage | — |
Quick Ratio
ACOU
Profitability
|
Metric
|
ACOU
|
|---|---|
Return on Assets (Normalized) | −61.09% |
Return on Equity (Normalized) | −106.50% |
Return on Invested Capital (Normalized) | −108.98% |
Return on Assets
ACOU
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Mmgfvlcgwz | Rrst | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Tccqpplym | Sxtzd | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jqghncx | Jxztfzx | $97.8 Bil | |
MRNA
| Moderna Inc | Vqtfckms | Gskz | $38.8 Bil | |
ARGX
| argenx SE ADR | Jtrgbtdr | Lvyb | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Zvmdnlglc | Ydhn | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Qgwcstzv | Rmmdxb | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Kqxbtxmv | Zqyyfs | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Ctrkxfywzx | Hfdsk | $12.5 Bil | |
INCY
| Incyte Corp | Yhfvcxm | Ppfpmv | $11.5 Bil |